Evolution of Next-Generation Multiplex Lateral Flow Immunoassays: From Engineered Nanomaterials to AI-Driven Detection
Biosensors · 07.05.2026 · 16 (5) · 269
DOI: 10.3390/bios16050269 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biosensors, online erschienen am 07.05.2026. Verfasst von Tan-Thanh Huynh und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering, Tra Vinh University, Vinh Long 85000, Vietnam. Hauptthemen laut MEDLINE: Artificial Intelligence, Nanostructures, Biosensing Techniques. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Taiwan, National Science and Technology Council in Taiwan.
Abstract (Originalsprache)
Decentralized diagnostics is undergoing a transformative shift from qualitative screening to high-precision quantification, driven by the clinical demand for rapid, point-of-care (POC) syndromic triage. Multiplexed lateral flow immunoassays (mLFIAs) serve as the foundational platform for this transition. However, their performance is limited by systemic factors such as fluidic lag, conjugate depletion, and spectral crosstalk. This review evaluates recent advances in engineered nanomaterials and artificial intelligence (AI)-driven detection as the dual pillars of next-generation multiplexing. The review covers different types of nanomaterial reporters—such as multicolor quantum dots, surface-enhanced Raman scattering nanotags, upconversion nanoparticles, surface-modified magnetic nanoparticles, and fluorescent nanodiamonds—that help address analytical challenges in lateral flow assays. We then discuss AI and machine learning methods, including convolutional neural networks, support vector machines, random forests, and transfer learning, that convert raw multi-channel signals into useful clinical data. Finally, we highlight the main challenges that still need to be addressed before these platforms can become WHO-ASSURED-compliant POC devices. The combination of engineered nanomaterial reporters and computational intelligence is transforming lateral flow assays into quantitative tools that can provide lab-quality clinical information at the POC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Chemical Engineering, Tra Vinh University, Vinh Long 85000, Vietnam.
- International Advanced Technology Program, College of Engineering, National Taiwan University of Science and Technology, Taipei 106, Taiwan.
- Department of Chemistry, National Taiwan Normal University, Taipei 116, Taiwan.
ORCID-Profile: Tan-Thanh Huynh, Duc-Thang Vo, Trong-Nghia Le
Förderung
- National Science and Technology Council, Taiwan
- National Science and Technology Council in Taiwan
Zitieren
APA
Huynh, T. T., Vo, D. T., & Le, T. N. (2026). Evolution of Next-Generation Multiplex Lateral Flow Immunoassays: From Engineered Nanomaterials to AI-Driven Detection. Biosensors, 16(5), 269. https://doi.org/10.3390/bios16050269
Vancouver
Huynh TT, Vo DT, Le TN. Evolution of Next-Generation Multiplex Lateral Flow Immunoassays: From Engineered Nanomaterials to AI-Driven Detection. Biosensors. 2026;16(5):269. doi:10.3390/bios16050269
BibTeX
@article{Huynh2026,
author = {Huynh, Tan-Thanh and Vo, Duc-Thang and Le, Trong-Nghia},
title = {Evolution of Next-Generation Multiplex Lateral Flow Immunoassays: From Engineered Nanomaterials to AI-Driven Detection},
journal = {Biosensors},
year = {2026},
volume = {16},
number = {5},
pages = {269},
doi = {10.3390/bios16050269}
}
EUVIMED